T3	Subject 26 55	adult Crohn's disease patient
T5	Treatment 110 131	long-term AZA therapy
T6	Effect 61 102	a parvovirus B19 infection and leukopenia
T7	Age 26 31	adult
T9	Treat-Disorder 32 47	Crohn's disease
T10	Drug 120 123	AZA
T11	Duration 110 119	long-term
T4	Adverse_event 103 109	during
E1	Adverse_event:T4